Treace Medical Concepts (TMCI) Shares Outstanding (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Shares Outstanding (Entity) for 7 consecutive years, with $65.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 2.95% year-over-year to $65.0 million; the trailing twelve-month figure through Jun 2026 stood at $65.0 million (up 2.95% YoY), and the FY2025 full-year result was $64.6 million, up 3.15% from the prior year.
• Shares Outstanding (Entity) steadied at $65.0 million in Q2 2026 per TMCI's latest filing, from $64.9 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $82.8 million in Q1 2022 and bottomed at $55.6 million in Q4 2022.
• Historically, Shares Outstanding (Entity) has averaged $65.7 million across 5 years, with a median of $62.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) slumped 32.82% in 2022, then gained 11.0% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $55.6 million in 2022, then climbed by 11.0% to $61.7 million in 2023, then grew by 1.41% to $62.6 million in 2024, then advanced by 3.15% to $64.6 million in 2025, then grew by 0.69% to $65.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $65.0 million, $64.9 million, and $64.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.